NewLink founder Charles Link told Reuters in Geneva: “The clinical trials do take some time. Everybody is trying as hard and furiously as possible to move those trials forward as rapidly as possible with the regulations, scientific and ethical constraints.
[eap_ad_4]
Page 2 of 2